The widespread adoption of artificial intelligence has moved well past basic automation. Generative AI and advanced machine learning are actively restructuring how life science, biotech, and pharmaceutical brands produce content, analyze market data, and connect with target audiences.
In an industry with complex scientific information and strict regulatory oversight, AI in pharma marketing can help teams work more efficiently. Using it effectively requires clear process for accuracy, data security, and content review.
1. Create and Adapt Marketing Content
Generative AI can help teams develop campaign concepts, explore visual directions, and draft headline options using past campaign materials, research, and creative briefs. It also supports first drafts of clinical summaries, white papers, and patient education resources.
Once a campaign direction is established, teams can use AI to prepare variations for different audiences:
- Adjust scientific detail for different HCP specialties.
- Simplify language for patient education.
- Draft translations and suggest regional adaptations.
- Develop messaging and visual options for different audience groups.
This can reduce the work involved in producing each variation. McKinsey estimates that generative AI could lower content creation costs by 30% to 50%. Actual savings depend on the workflow, implementation, and review requirements.
2. Personalize HCP Engagement and Support Field Teams
AI-enabled CRM systems can bring together engagement history, physician specialty, and appropriately accessed prescribing and treatment data. These insights help teams create more focused audience segments and plan relevant communication.
Generative AI helps turn that information into practical resources for field representatives, including:
- Summaries of previous interactions and discussion topics.
- Suggested talking points for upcoming visits.
- Recommendations for approved follow-up materials.
- Draft emails tailored to the HCP’s interests.
Predictive models can help recommend the next action, while generative AI prepares the supporting summaries and content. Salesforce’s life sciences tools illustrate how these capabilities can support visit planning and follow-up.
For patient communications, audience insights can also inform educational resources based on expressed needs and interests, using data the organization is permitted to access.
3. Improve Campaign Testing and Optimization
Generative AI can help teams prepare more copy and creative options for testing. Marketers can compare different headlines, messages, and formats to learn what resonates with their audiences.
Other AI capabilities support campaign delivery by adjusting bids, targeting, and placements based on performance signals. Together, these tools help teams:
- Develop variations for controlled testing.
- Identify stronger-performing messages and audiences.
- Summarize changes in campaign performance.
- Make informed decisions about budget allocation.
Google Ads documentation describes this combination of creative AI generation and automated optimization. Pharma teams still need to check platform eligibility, advertising policies, and content approval requirements before using these features.
4. Support Medical, Legal, and Regulatory Review
Producing more content also creates more material to review. A ZS analysis found that promotional assets can take 20 to 50 days to move through approval, including multiple review rounds.
Generative AI can help prepare materials for medical, legal, and regulatory (MLR) review by:
- Identifying differences from previously approved claims.
- Suggesting source references for reviewers to verify.
- Checking for label updates and missing information.
- Flagging language or visuals that may need closer attention.
- Applying feedback from earlier reviews to new drafts.
The opportunity is to reduce avoidable rework and give reviewers better-prepared submissions. McKinsey estimates potential content approval speeds of two to three times the current pace. These figures describe potential workflow improvements, rather than guaranteed results.
5. Use Market Data to Guide Strategy and Forecasting
Pharma marketers often need to combine information from dashboards, research reports, clinical publications, and call transcripts. Generative AI can help teams search and summarize these sources through a conversational interface.
For example, a marketer could ask which questions appear most often in HCP conversations or how audience engagement differs across regions. The resulting summaries can help teams identify issues worth investigating and adjust their plans.
Alongside generative AI, predictive models can help forecast commercial demand and supply needs. Those forecasts can inform inventory planning and marketing spend. Teams need to validate the findings before making business decisions.
Advantages of Generative AI in Pharma Marketing
Gen AI can help pharma marketing teams produce content more efficiently, make better use of information, and support audience needs.
- Faster content production: Teams can draft campaign variations, adapt existing materials, and prepare content for different audiences. This reduces repetitive work and gives staff more time for strategy and review.
- More accessible insights: Generative AI can summarize research, campaign reports, and customer feedback, helping marketers identify recurring questions and opportunities to improve communication.
- Ongoing audience support: AI-assisted tools can help HCPs and patients find approved educational resources outside business hours, with clear routes to human support for questions that require professional judgment.
Disadvantages of Generative AI in Pharma Marketing
These benefits depend on careful implementation. Inaccurate information, sensitive data, and generic messaging require ongoing attention.
- Inaccurate information: AI can generate incorrect claims, statistics, and citations, even when it uses trusted sources. Teams need to verify scientific accuracy and supporting references before publishing.
- Privacy and security risks: AI tools may process sensitive customer or patient information. Organizations need to control data access, understand how providers store and use information, and meet applicable privacy requirements.
- Generic or misleading content: Automated writing can sound repetitive or lose important scientific context when simplifying information. Human experts need to guide the messaging, preserve the brand’s voice, and review content for accuracy and audience relevance.
AI Solutions for Pharma Marketing from Arc Intermedia
Arc Intermedia helps businesses identify where AI can improve their marketing and day-to-day workflows. For pharmaceutical and biotech brands, that starts with understanding your team’s needs, the information you work with, and the review processes your content must follow.
Since 2010, we’ve helped companies make better use of their marketing budgets. We bring that same focus to AI, identifying practical opportunities to reduce repetitive work and give your team more time for strategy and decision-making. Hear from our clients about the expertise and collaboration we bring to their businesses or view our case studies to see the type of success we’ve delivered to companies.
Explore all our AI solutions including agent development, sales process automation, content development tools, and more or contact us to discuss how AI could support your pharma marketing team.
